InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Prentiss Christopher B, Chief Financial Officer. Officer active across 1 company, notably Adamas Pharmaceuticals Inc. In total, 2 reports have been published. History available since 24 November 2021. The latest transaction was filed on 24 November 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
18,750 shares0Common StockSEC:0001328143-21-000092:0
18,750 shares0Common StockSEC:0001328143-21-000092
2 of 2 declarations
About Prentiss Christopher B
Christopher B. Prentiss is the Chief Financial Officer of Adamas Pharmaceuticals Inc. He oversees the company's financial operations, including budgeting and risk management. Adamas Pharmaceuticals focuses on developing treatments for neurological diseases. Christopher's expertise in finance is essential to ensure the company's financial health.
